about
Cortical metabolic arrangement during olfactory processing: proposal for a 18F FDG PET/CT methodological approach.Cortico-subcortical metabolic correlates of olfactory processing in healthy resting subjects.Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease?: A 18F-FDG PET/CT study.Early and phasic cortical metabolic changes in vestibular neuritis onset.Brain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An 18F-FDG PET/CT study.Cerebellar metabolic involvement and its correlations with clinical parameters in vestibular neuritis.Involvement of Subcortical Brain Structures During Olfactory Stimulation in Multiple Chemical Sensitivity.Complement C3 Is the Strongest Predictor of Whole-Body Insulin Sensitivity in Psoriatic Arthritis.Initial staging of Hodgkin's disease: role of contrast-enhanced 18F FDG PET/CTEarly cortical metabolic rearrangement related to clinical data in idiopathic sudden sensorineural hearing loss.Aspects of cerebral plasticity related to clinical features in acute vestibular neuritis: a "starting point" review from neuroimaging studies.Reverse perfusion pattern in myocardial spect with 99mTc-sestaMIBI.Evaluation of recurrent disease in the re-staging of colorectal cancer by 18F-FDG PET/CT: Use of CEA and CA 19-9 in patient selection.PET Probe-Guided Surgery in Patients with Breast Cancer: Proposal for a Methodological ApproachWIDEN: A tool for medical image management in multicenter clinical trials.Cerebral metabolic changes related to clinical parameters in idiopathic anosmic patients during olfactory stimulation: a pilot investigation.Usefulness of 18F Florbetaben in Diagnosis of Alzheimer's Disease and Other Types of Dementia.Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.Comparison between Early-Onset and Late-Onset Alzheimer's Disease Patients with Amnestic Presentation: CSF and (18)F-FDG PET Study.Subependymal Spread of Glioblastoma Multiforme in Positron Emission Tomography/Computed Tomography.Quantitative analysis of basal and interim PET/CT images for predicting tumor recurrence in patients with Hodgkin's lymphoma.18F-DOPA PET/CT Physiological Distribution and Pitfalls: Experience in 215 Patients.(18)F-choline PET/CT pitfalls in image interpretation: an update on 300 examined patients with prostate cancer.Does 123I-MIBG scintigraphy really assist the diagnosis of Parkinson's disease?Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study.PET/CT with 18F-choline: Physiological whole bio-distribution in male and female subjects and diagnostic pitfalls on 1000 prostate cancer patients: 18F-choline PET/CT bio-distribution and pitfalls. A southern Italian experience.Coupled Imaging with [18F]FBB and [18F]FDG in AD Subjects Show a Selective Association Between Amyloid Burden and Cortical Dysfunction in the Brain.(18)F FDOPA uptake in brain metastasis of breast cancer.Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease.Is cerebral glucose metabolism affected by chemotherapy in patients with Hodgkin's lymphoma?Cortical activity during olfactory stimulation in multiple chemical sensitivity: a (18)F-FDG PET/CT study.Functional correlates of t-Tau, p-Tau and Aβ₁₋₄₂ amyloid cerebrospinal fluid levels in Alzheimer's disease: a ¹⁸F-FDG PET/CT study.Factors affecting ¹⁸F FDOPA standardized uptake value in patients with primary brain tumors after treatment.A case of intracranial meningioma detected by ¹⁸F-choline PET/CT and examined by PET/MRI fusion imaging.Do CSF levels of t-Tau, p-Tau and β₁₋₄₂ amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A ¹²³I-FP-CIT study in the early stages of the disease.18F-DOPA PET/CT and MRI Findings in a Patient With Multiple Meningiomas.Transient parkinsonism after unilateral midbrain stroke: a compensatory intervention from the healthy side?Different patterns of cardiac sympathetic denervation in tremor-type compared to akinetic-rigid-type Parkinson's disease: molecular imaging with ¹²³I-MIBG.Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT.Evaluation of extraprostatic disease in the staging of prostate cancer by F-18 choline PET/CT: can PSA and PSA density help in patient selection?
P50
Q30400446-518BF641-4795-4B5D-96CA-8A095CD993B0Q30436870-A3F0F01A-DC05-4342-8419-420A869BAE80Q33595086-790F9EB1-6FAA-4886-A45E-CA12F9E95309Q34625553-AFAC198F-2B09-4FBD-9A8B-DB42D0ED7960Q34993792-D9A7EC66-90CD-4EE8-B10D-CC296ADA4A96Q35216928-A73BB037-1E5B-4848-BA37-7F386A0E4486Q35799867-D804D6DF-67B0-48D9-88B9-B179382E015FQ36140527-3AA89DE6-294E-45C8-B095-C6B3613F4FE2Q36150877-453633D2-DCB7-4201-BEA2-DB73CBE5285EQ36359906-9791B30C-B988-4A3E-80E0-F13AA2BB51DAQ37002360-02FC18D5-569B-4AAA-9467-2E47BFDCDC87Q37206197-48AD96DC-C3FA-410C-AC62-AFB70FE1A7D0Q37407345-9C7A0979-FC48-490E-B6EE-307067736E9CQ37705266-BCB12F2F-4D47-48FF-9089-686D5EB18916Q38202946-8DAED37D-8B2F-40B7-844B-5DC439F071E7Q38747398-6C9D941F-9995-431B-81B3-BE479EEC898AQ38873930-090C7BC4-9DBA-4E87-8DDE-0E372B02116CQ39738826-CE1409C0-64F8-4F60-8997-BD77DAA8564BQ41949381-11ACE055-AA4C-4719-8469-F116CBD94C57Q42320684-F53D8F64-4336-49FA-8E7A-D91EB7002A4EQ42483323-668B77B6-0A31-425C-A674-0E97A8A58769Q42496761-5904C8DC-9F2B-48F2-B382-C7BDCB2FDB0EQ45388830-F10332F3-99E2-4D5F-A318-B366FCA9F37BQ46385451-863FF9A9-AEEF-41BD-9CDF-667B92473348Q47589923-0F729C5F-8370-48EA-B747-5F518F277F34Q47743775-06943497-8E73-4D59-9394-FE769854C6B4Q48101119-B291EBE7-8807-407F-8354-D1C04EC0BD48Q48106225-730E786A-BE45-44C3-9744-A0D2500495F1Q48147522-7A7D9E03-1FDD-4130-A2EF-430EF9C53EBAQ48318320-BA4A46CB-A52D-4856-AFE0-3F47F8ADC327Q48323863-98DFA2DD-9C8D-4A84-850E-E0F86FBB4090Q48346607-B56FBBC0-3159-43C1-A2A5-117746D171FAQ48358663-69755D22-655C-42D6-A5BC-30BB39205453Q48662895-C286D514-EE74-468A-BD5E-0CD85E08DF06Q48668610-ED8703DE-8DCD-480A-ADC4-D2B58C983A06Q48730950-62A0C6ED-60F3-4E5E-9DE7-76FB6AE5A3F3Q48774740-39407FD0-773E-4C05-990E-7FEA00A96FCEQ50253856-AEFD3D77-8E06-4432-B053-9944F5A026BEQ50263173-CB22CD39-2654-4E29-BDF6-29B41708BA44Q50988340-1E76C116-40E3-4791-88DE-EF2C2B353375
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Agostino Chiaravalloti
@ast
Agostino Chiaravalloti
@en
Agostino Chiaravalloti
@es
Agostino Chiaravalloti
@nl
type
label
Agostino Chiaravalloti
@ast
Agostino Chiaravalloti
@en
Agostino Chiaravalloti
@es
Agostino Chiaravalloti
@nl
prefLabel
Agostino Chiaravalloti
@ast
Agostino Chiaravalloti
@en
Agostino Chiaravalloti
@es
Agostino Chiaravalloti
@nl
P106
P1153
55087901500
P21
P31
P496
0000-0002-8017-8858